Kristin Abate Karyopharm Therapeutics Inc. (KPTI) insider trading activity
Kristin Abate is Chief Accounting Officer of Karyopharm Therapeutics Inc.. Currently has a direct ownership of 9,475 shares of KPTI, which is worth approximately $37,615. The most recent transaction as insider was on Jul 22, 2025, when has been sold 238 shares (Common Stock) at a price of $4.0 per share, resulting in proceeds of $952. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).
Shares Held (Direct Ownership)
9.48K
2.45%
3M change
n/a
12M change
Total Value Held
$37,615
Kristin Abate Transaction History
KA
Kristin Abate
Chief Accounting Officer
Newton, MA